E. Ohman J or Asset Management AB Has $28.57 Million Position in Surgery Partners, Inc. (NASDAQ:SGRY)

E. Ohman J or Asset Management AB grew its holdings in shares of Surgery Partners, Inc. (NASDAQ:SGRY) by 31.0% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 886,088 shares of the company’s stock after buying an additional 209,888 shares during the quarter. E. Ohman J or Asset Management AB owned approximately 0.70% of Surgery Partners worth $28,567,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Quarry LP raised its holdings in Surgery Partners by 133.1% during the second quarter. Quarry LP now owns 3,082 shares of the company’s stock worth $73,000 after acquiring an additional 1,760 shares in the last quarter. DekaBank Deutsche Girozentrale raised its stake in shares of Surgery Partners by 102.0% during the 1st quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after purchasing an additional 1,375 shares in the last quarter. EntryPoint Capital LLC boosted its holdings in shares of Surgery Partners by 257.1% in the 1st quarter. EntryPoint Capital LLC now owns 6,399 shares of the company’s stock valued at $191,000 after buying an additional 4,607 shares during the last quarter. Creative Planning acquired a new stake in shares of Surgery Partners in the 3rd quarter valued at approximately $258,000. Finally, Capstone Investment Advisors LLC grew its stake in shares of Surgery Partners by 38.7% in the first quarter. Capstone Investment Advisors LLC now owns 9,151 shares of the company’s stock valued at $273,000 after buying an additional 2,551 shares in the last quarter.

Surgery Partners Stock Performance

Shares of NASDAQ SGRY opened at $30.87 on Friday. The company has a debt-to-equity ratio of 0.96, a current ratio of 1.83 and a quick ratio of 1.69. The firm has a market cap of $3.92 billion, a price-to-earnings ratio of -114.33, a P/E/G ratio of 2.45 and a beta of 2.75. The stock’s fifty day moving average price is $31.26 and its two-hundred day moving average price is $28.05. Surgery Partners, Inc. has a one year low of $22.05 and a one year high of $36.92.

Surgery Partners (NASDAQ:SGRY) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.21 earnings per share for the quarter, topping the consensus estimate of $0.20 by $0.01. Surgery Partners had a negative net margin of 1.17% and a positive return on equity of 2.96%. The business had revenue of $762.10 million during the quarter, compared to analysts’ expectations of $735.94 million. During the same quarter in the previous year, the company earned $0.25 EPS. The business’s revenue was up 14.2% on a year-over-year basis. On average, equities analysts forecast that Surgery Partners, Inc. will post 0.84 EPS for the current year.

Wall Street Analysts Forecast Growth

SGRY has been the subject of a number of recent analyst reports. Citigroup cut their price target on shares of Surgery Partners from $38.00 to $36.00 and set a “buy” rating for the company in a research note on Wednesday, August 7th. StockNews.com cut Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. KeyCorp assumed coverage on Surgery Partners in a research note on Friday, October 11th. They issued a “sector weight” rating on the stock. Macquarie began coverage on Surgery Partners in a research note on Friday, June 28th. They set an “outperform” rating and a $31.00 target price for the company. Finally, Royal Bank of Canada restated an “outperform” rating and issued a $49.00 price target on shares of Surgery Partners in a research note on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, two have given a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Surgery Partners currently has a consensus rating of “Moderate Buy” and an average target price of $39.63.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.